SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    UK Cannabis Lawyers Memery Crystal Bought By City Firm For £30m

    By

    RESPECTED UK cannabis law firm Memery Crystal has been bought by City firm RBG Holdings for £30m. 

    Memery Crystal handled the legal aspects of the flotation of the first cannabis company – MGC Pharmaceuticals – on to the London Stock Exchange, in February this year.

    Its Managing Director Nick Davis is well-known in the industry with the firm currently acting for a number of cannabis companies looking at London floats and fundraising.

    Mr Davis will remain with the firm which will retain its own brand identity and separate offices. RBG Holdings plc was previously known as Rosenblatt and is listed on the Alternative Investment Market. 

    Nick Davis

    Nicola Foulston, chief executive of RBG Holdings, said: “Memery Crystal is an excellent addition to the group both culturally and operationally. Both businesses are entrepreneurial in nature.”

    Memery Crystal has 29 partners and the deal involves RBG paying £12m in cash, £11.2m in shares and £6.8m in deferred shares, reports The Times. 

    As well as cannabis Memery Crystal has a strong presence across the capital markets, private wealth, finance, real estate, technology retail, leisure and natural resources.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Peter

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free